Allakos Inc

Overview

Allakos Inc (Allakos) is a clinical stage biotechnology company which develops antibodies that target immunomodulatory receptors present on immune effector cells. The company operates in the therapeutic areas of allergic, inflammatory, and proliferative diseases. It investigates in the therapeutic areas of eosinophilic gastrointestinal diseases , inflammatory diseases with continuing gastrointestinal symptoms along with an increase in the count of mast cells in the body. The company's product offerings include AK002, an antibody that targets Siglec-8, an inhibitory receptor for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, urticaria, indolent systemic and mastocytosis. The company has operations in the US. Allakos is headquartered in Redwood City, California, the US.
Key Stats
Address
975 Island Dr Ste 201, REDWOOD CITY, California
Headquarters

United States of America

Contact

1 650 5975002

Website
www.allakos.com
No of Employees

151

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

ALLK [NASD]

Net Income (2020)

$-153 m

-79.2% (2020 vs 2019)
Market Cap *

$5,347 m

EPS *

$-3.1

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Allakos IncKymera Therapeutics, IncCyclacel Pharmaceuticals Inc
Key Information
Headquarters United States of America United States of America United States of America
Headquarter City REDWOOD CITY WATERTOWN BERKELEY HEIGHTS
Headquarter State/Province California Massachusetts New Jersey
No. of Employees 151 112 12
Entity Type Public Public Public

Products & Services

Allakos is a clinical stage biotechnology company based in the US. The key products under development offered by the company include the following:

Products
  • Pipeline
  • AK002:
  • Allergic, Inflammatory, and Proliferative Diseases

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2012 Incorporation/Establishment In March, the company was incorporated.

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
10 May 2021 Allakos to Raise USD400 Million in Public Offering of Shares Equity Offering Allakos Inc
27 Oct 2020 Allakos Raises USD287.5 Million in Public Offering of Shares Equity Offering Allakos Inc
05 Aug 2019 Allakos Raises USD402.5 Million in Public Offering of Shares Equity Offering Allakos Inc
18 Jul 2018 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
18 Jul 2018 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
18 Jul 2018 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

17

Active Jobs

0

Posted

5

Closed

Job Trends

Latest Jobs

Job title Company Country
Manager/Sr Manager of Large Scale External DS Manufacturing Allakos Inc United States
Senior Clinical Study Associate Allakos Inc United States
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar